Docetaxel Chemotherapy of Korean Patients with Hormone-refractory Prostate Cancer : Comparative Analysis between 1st-line and 2nd-line Docetaxel

PURPOSE: This study was undertaken to investigate the outcomes associated with docetaxel treatment of Korean patients with hormone-refractory prostate cancer (HRPC) and to compare its clinical efficacies in 1st and 2nd-line settings. MATERIALS AND METHODS: This study was retrospectively performed an...

Descripción completa

Detalles Bibliográficos
Autores principales: Joung, Jae Young, Jeong, In Gab, Han, Kyung Seok, Kim, Taek Sang, Yang, Seung Ok, Seo, Ho Kyung, Chung, Jinsoo, Cho, Kang Su, Lee, Kang Hyun
Formato: Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615369/
https://www.ncbi.nlm.nih.gov/pubmed/18972598
http://dx.doi.org/10.3349/ymj.2008.49.5.775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615369/
https://www.ncbi.nlm.nih.gov/pubmed/18972598
http://dx.doi.org/10.3349/ymj.2008.49.5.775

Ejemplares similares